Plasma p-tau181 is a promising biomarker that can help identify Alzheimer's disease pathology and distinguish those who are at risk for conversion to dementia.

Researchers from Queen Mary University of London have developed and validated a new tool that could help GPs detect ovarian ...

Objectives The central nervous system is a significant extraglandular target in primary Sjögren’s syndrome (pSS), often ...